Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives.
Ontology highlight
ABSTRACT: Alzheimer's disease (AD), one of the main causes of aged dementia, is a progressive and degenerative neurological disorder characterized by loss of cognition and memory. Although the symptomatic treatment of AD, particularly acetylcholinesterase inhibitors (AChEIs) based on the 'cholinergic hypothesis', has been successful in clinic, at present there is no cure for this disease. In this study, we designed compounds carrying benzimidazole and triazole rings on the same chemical skeleton so as to investigate their potential acetylcholinesterase and butyrylcholinesterase activity. Furthermore, molecular modeling study was performed to determine the binding mode of the best inhibitor to the AChE. Among them, compounds 3d and 3h, which featured 3,4-dihydroxy substitution at the ph
SUBMITTER: Acar Cevik U
PROVIDER: S-EPMC6429502 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA